Don't Revive Restasis Patents, Generic Cos. Urge Fed. Circ.
A Texas federal judge rightly invalidated claims from four patents covering Allergan's dry-eye medicine Restasis, as they directly copied earlier patents the drugmaker had filed, a trio of generic-drug makers told...To view the full article, register now.
Already a subscriber? Click here to view full article